Chime Biologics supports Mabgeek to advance MG-K10, a novel IL-4Ra-targeting antibody drug for atopic dermatitis and ...
Chime Biologics, a leading global CDMO that enables its partners’ success in biologics, announced its continued collaboration with Mabgeek in advancing MG-K10, a potential Best-in-Class therapy, a novel IL-4Ra-targeting antibody drug for atopic dermatitis …